Professor of Colorectal Surgical Oncology, Consultant Surgeon, School of Cancer Sciences, University of Glasgow, Glasgow Royal Infirmary @grisurgery
Glasgow, Scotland
Joined May 2011
- Tweets595
- Following480
- Followers991
- Likes1.2K
Congratulations @RK_McMahon on a successful PhD thesis defence today: Investigating clinical pathological characteristics of RT response in locally advanced rectal cancer 👏👏👏🎉🍾 - thanks to Rebecca Muirhead and @mansouridave for participating in the viva @grisurgery
Campbell Roxburgh retweeted
What an entertaining session at #ESTRO26 - 4 experts advocating for 4 different treatment approaches in a rectal cancer case. @AliceCouwenberg @C_Roxburgh @KarynAGoodman @MontefioreD @Pier_Franco_MD @KrishanJethwa
👏👏👏
FOxTROT 5 testing peri-op dostarlimab in MSI-H locally advanced colon cancer in older or frail patients. Thanks to our fantastic 🇬🇧 investigators.
FOxTROT 6 to follow soon….
@yorkshirecancer @adbeggs @JenSeligmann @LTHTResearch
Thanks for the invitation to talk to an amazing group of young people interested in Medicine. Lots of great questions and enthusiasm. Especially nice to visit @StAndrewsRCSec which is just alone the road from @grisurgery
Our Medical Society welcomed colorectal surgeon @C_Roxburgh from @UofGlasgow and Glasgow Royal Infirmary today. Of great interest was his work on cancer surgery and the use of robotics.
@NMacLellan1 @StAndrews_2030 @Moolan1008 @amygoo27 @ScollinMr @MrsLMaughan
Campbell Roxburgh retweeted
A couple of weeks ago, during the International Surgery Course Dr. Hector Orozco, we had the privilege of hosting @C_Roxburgh , colorectal surgeon from Glasgow 🏴.
Thankful for his insights and to my mentors for fostering these invaluable learning opportunities.
Great to see #rectalcancer research from @lily_hillson @UofGCancerSci in press! Important data from standard of care treatments relevant to PRIME-RT and other RT immunotherapy trials. Congratulations to Lily. @OcathailS
Now online: Differential Immunological Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer doi.org/10.1158/1078-0432.CC…
Campbell Roxburgh retweeted
Immunological Dynamics in Rectal Cancer: SCRT vs LCRT @CCR_AACR
◾️Circulating lymphocytes: SCRT (less depletion) > LCRT
◾️Immune cells in TME: SCRT (higher density of CD8+ & FOXP3+) > LCRT, no diff. in FOXP3/CD8 ratio
👉SCRT is potentially preferred backbone in combination with ICIs
doi.org/10.1158/1078-0432.CC…
@OncoAlert @C_Roxburgh
Campbell Roxburgh retweeted
Great to hear from @C_Roxburgh and Tom Bird @ScotCancerConf - how collaboration among scientists across Scotland is transforming survival for those with rectal and liver cancers.
A position for our Colorectal RAS fellowship @grisurgery @wearehairmyres @qeuh_surgery starting in April has become available. Please get in touch with any of us if interested👇
acpgbi.org.uk/about/news/571…
Thank you to @epipatelmd for the kind invitation. It’s been fantastic to visit @
@queensu to work on strengthening 🇨🇦 and 🏴 🇬🇧 links and collaborations.
Excited to listen to @C_Roxburgh today at @queensoncology Grand Rounds about IO-RT combination strategies in rectal cancer.
Campbell Roxburgh retweeted
Post-neoadjuvant modified Glasgow prognostic score associated with poorer response and tumor regression in LARC pots following neoadjuvant therapy. Read more in this month's #DCRJournal: bit.ly/3HuJJkV
@RK_McMahon @C_Roxburgh
Congratulations to Josh McGovern on successfully navigating his PhD viva @grisurgery today. 👏👏👏
Thanks to Neil Johns and Rachel Kearns for examining. Fantastic work Josh!
Campbell Roxburgh retweeted
FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients - @JenSeligmann
@C_Roxburgh @LTHTResearch
oncodaily.com/drugs/jenny-se…
#ColonCancer #CRC #CancerPatients #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
Five Major Advances in Anal and Rectal Cancer Treatment with Radiotherapy: A New Era of Organ-Preserving Options azooptics.com/News.aspx?news…
Campbell Roxburgh retweeted
Exciting news for rectal cancer patients - results from a Glasgow clinical trial provide new hope
heraldscotland.com/news/2513…
Incredible results from Chinese STELLAR 2 trial in #rectalcancer at #ESTRO25 which shows improved outcomes either immunotherapy and TNT vs TNT alone. Supports SCRT as iTNT backbone.
🔵 #ESTRO25 Press release
#Immunotherapy Combined with #Radiotherapy and #Chemotherapy Reduces the Need for #Surgery in Locally Advanced #rectalcancer.
👉 bit.ly/3ESKqDO
